The Journal of Immunology, Vol 153, Issue 2 701-711, Copyright © 1994 by American Association of Immunologists

ARTICLES

Comparison of two promoters controlling expression of secreted or intracellular IL-1 receptor antagonist

C Butcher, A Steinkasserer, S Tejura and AC Lennard
Yamanouchi Research Institute U.K. Littlemore Hospital, Oxford, England.

IL-1R antagonist can be expressed as a secreted glycoprotein (sIL-1Ra) or as an intracellular nonglycosylated form (icIL-1Ra). The two isoforms only differ in their N-terminal sequences and are thought to originate, by selection of alternative first exons, from a single gene (IL-1RN). We have previously described a clone that encodes the exons and promoter for sIL-1Ra. In this work, we describe and characterize a clone that contains the further upstream, alternative first exon used to generate icIL-1Ra. Sequences upstream to this alternative exon are demonstrated to have promoter activity in the human colon epithelial cell line HT29, whereas the sIL-1Ra promoter has undetectable activity. Both the icIL-1Ra and sIL-1Ra promoters were active when transfected into THP-1 cells. Neither promoter was responsive to PMA or LPS when introduced into HT29 or THP-1 cells. Activity of the endogenous icIL- 1Ra and sIL-1Ra promoters was also investigated. In agreement with the transfected icIL-1Ra promoter, the endogenous icIL-1Ra gene is active in HT29 cells, though induced by PMA. In contrast to the transfected icIL-1Ra promoter, the endogenous icIL-1Ra gene is inactive in THP-1 cells and induced by PMA. Our data complete the structure of the human IL-1RN gene, demonstrating that the two forms of IL-1Ra are produced from the same gene by use of alternative first exons. We also show that there are two distinct promoters that control IL-1Ra expression, that lie upstream to each alternative first exon.

This article has been cited by other articles:

				J. Kong, S. A. Grando, and Y. C. Li Regulation of IL-1 Family Cytokines IL-1{alpha}, IL-1 Receptor Antagonist, and IL-18 by 1,25-Dihydroxyvitamin D3 in Primary Keratinocytes J. Immunol., March 15, 2006; 176(6): 3780 - 3787. [Abstract] [Full Text] [PDF]

				E. La and S. M. Fischer Transcriptional Regulation of Intracellular IL-1 Receptor Antagonist Gene by IL-1{{alpha}} in Primary Mouse Keratinocytes J. Immunol., May 15, 2001; 166(10): 6149 - 6155. [Abstract] [Full Text] [PDF]

				G. C. Higgins, Y. Wu, and A. E. Postlethwaite Intracellular IL-1 Receptor Antagonist Is Elevated in Human Dermal Fibroblasts That Overexpress Intracellular Precursor IL-1{alpha} J. Immunol., October 1, 1999; 163(7): 3969 - 3975. [Abstract] [Full Text] [PDF]

				C. Gabay, B. Porter, D. Guenette, B. Billir, and W. P. Arend Interleukin-4 (IL-4) and IL-13 Enhance the Effect of IL-1beta on Production of IL-1 Receptor Antagonist by Human Primary Hepatocytes and Hepatoma HepG2 Cells: Differential Effect on C-Reactive Protein Production Blood, February 15, 1999; 93(4): 1299 - 1307. [Abstract] [Full Text] [PDF]

				M. F. Smith Jr., V. S. Carl, T. Lodie, and M. J. Fenton Secretory Interleukin-1 Receptor Antagonist Gene Expression Requires both a PU.1 and a Novel Composite NF-kappa B/PU.1/ GA-binding Protein Binding Site J. Biol. Chem., September 11, 1998; 273(37): 24272 - 24279. [Abstract] [Full Text] [PDF]

				M. Malyak, M. F. Smith Jr., A. A. Abel, K. R. Hance, and W. P. Arend The Differential Production of Three Forms of IL-1 Receptor Antagonist by Human Neutrophils and Monocytes J. Immunol., August 15, 1998; 161(4): 2004 - 2010. [Abstract] [Full Text] [PDF]

				J. Sauer, U. Renner, U. Hopfner, M. Lange, A. Müller, C. J. Strasburger, U. Pagotto, E. Arzt, and G. K. Stalla Interleukin-1{beta} Enhances Interleukin-1 Receptor Antagonist Content in Human Somatotroph Adenoma Cell Cultures J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2429 - 2434. [Abstract] [Full Text]

				M.-L. Wong, P. B. Bongiorno, V. Rettori, S. M. McCann, and J. Licinio Interleukin (IL) 1beta , IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: Pathophysiological implications PNAS, January 7, 1997; 94(1): 227 - 232. [Abstract] [Full Text] [PDF]